Acorda Therapeutics Inc Valeur / Action
Quel est le Valeur / Action de Acorda Therapeutics Inc?
Le Valeur / Action de Acorda Therapeutics Inc est -8.21
Quelle est la définition de Valeur / Action?
La valeur comptable par action est l'actif de la société moins le passif divisé par le nombre d'actions en circulation.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valeur / Action des entreprises dans Health Care secteur sur NASDAQ par rapport à Acorda Therapeutics Inc
Que fait Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Entreprises avec valeur / action similaire à Acorda Therapeutics Inc
- Opto Circuits (India) a Valeur / Action de -8.45
- California Resources Corp a Valeur / Action de -8.41
- MBIA a Valeur / Action de -8.37
- Dynavision a Valeur / Action de -8.27
- Vivint Smart Home Inc a Valeur / Action de -8.24
- Rusoro Mining a Valeur / Action de -8.22
- Acorda Therapeutics Inc a Valeur / Action de -8.21
- Town Sports International a Valeur / Action de -8.11
- MDC Partners a Valeur / Action de -8.06
- Ansal Properties & Infrastructure a Valeur / Action de -8.05
- Lanesborough Real Estate Investment Trust a Valeur / Action de -8.04
- Mechel PJSC a Valeur / Action de -7.79
- Setco Automotive a Valeur / Action de -7.77